1. Home
  2. Clinical Topics
  3. FDA advises women with breast impants
Clinical TopicsDrugs and DevicesNewsOncologyWeb ExclusivesWomen's Health

FDA advises women with breast impants


The U.S. Food and Drug Administration says women with breast implants may have a “very small, but increased risk” of developing anaplastic large cell lymphoma (ALC). The FDA adds that “the known ALCL cases are too few to say conclusively that breast implants cause the disease.” Read more at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm240985.htm and http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm241086.htm.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts